Immediate Impact
53 standout
Citing Papers
Glioblastoma: Clinical Presentation, Multidisciplinary Management, and Long-Term Outcomes
2025 Standout
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
2025 Standout
Works of Polina Kaplan being referenced
ASCEND: Phase III, Randomized Trial of Acalabrutinib Versus Idelalisib Plus Rituximab or Bendamustine Plus Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia
2020 Standout
Acalabrutinib vs Rituximab Plus Idelalisib (IdR) or Bendamustine (BR) by Investigator Choice in Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia: Phase 3 ASCEND Study
2019
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Polina Kaplan | 272 | 220 | 111 | 9 | 319 | |
| Laurie Musial | 263 | 218 | 133 | 8 | 345 | |
| Rose Mantel | 244 | 185 | 96 | 13 | 317 | |
| M. Lenoci | 202 | 180 | 106 | 10 | 347 | |
| Viralkumar Patel | 180 | 116 | 60 | 11 | 347 | |
| Talha Munir | 308 | 252 | 95 | 14 | 340 | |
| Binsah George | 250 | 187 | 99 | 8 | 284 | |
| Francesca Yates | 254 | 200 | 92 | 10 | 272 | |
| Adam Albitar | 230 | 185 | 51 | 8 | 269 | |
| E Moreau | 241 | 218 | 32 | 7 | 310 | |
| Abigail S. Kelliher | 173 | 157 | 132 | 9 | 361 |
All Works
Loading papers...